FINWIRES · TerminalLIVE
FINWIRES

Greater Toronto Area Resale Condo Prices "May Not Trend Higher In Earnest until 2028", says TD Economics

By

-- Benchmark Greater Toronto Area resale condo prices fell 10% year over year in Q1, and "subdued" demand relative to supply suggests further price declines through 2026, said TD Economics on Tuesday.

The bank did add: "Next year, better affordability, waning uncertainty, pent-up demand and firmer labor market conditions should lift sales and help draw down inventories, improving the trajectory for prices."

But it also said: "With population growth weak, investor demand constrained, and interest rates unlikely to add much support, prices may not trend higher in earnest until 2028, leaving the downturn close to six years in total. By that time, prices will have fallen by around 25% to 30% from their early 2022 peak."

Related Articles

Mining & Metals

RBC Maintains Suncor Energy's Outperform Rating, C$100 Price Target

RBC Capital Markets on Wednesday reiterated Suncor Energy's (SU.TO) outperform rating and C$100 price target, with the bank noting the company delivered another quarter of "robust performance" punctuated by a "jumbo-sized" downstream pre-tax margin of $2 billion (including FIFO gains) in part driven by record refined product sales of 680,900 bbl/d.RBC's updated production outlook of 862,100 bbl/d, anchored by a $5.7 billion capital program, remains relatively unchanged."Suncor's first-quarter results reinforced our confidence that its culture of sustained high performance is taking deep root and enabling the company to be on the podium, come what may," RBC said. "We believe the ingredients are in place for the company to earn a premium relative valuation, conceivably over the next year," RBC added.Suncor is RBC's favorite integrated producer in Canada and is part of its Global Energy Best Ideas list.Suncor traded at $85.70 per share at last look Thursday on the Toronto Stock Exchange.Price: $85.70, Change: $-2.21, Percent Change: -2.51%

$SU.TO
Australia

RBC Capital Adjusts VSE Price Target to $240 From $220, Maintains Outperform Rating

VSE (VSEC) has an average rating of Buy and mean price target of $248.50, according to analysts polled by FactSet.Price: $206.85, Change: $-0.60, Percent Change: -0.29%

$VSEC
Australia

RBC Capital Adjusts United Therapeutics Price Target to $701 From $707, Maintains Outperform Rating

United Therapeutics (UTHR) has an average rating of buy and mean price target of $670.67, according to analysts polled by FactSet.Price: $585.63, Change: $-11.14, Percent Change: -1.87%

$UTHR